147 related articles for article (PubMed ID: 17164260)
21. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
22. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.
Martín-Guerrero I; Enjuanes A; Richter J; Ammerpohl O; Colomer D; Ardanaz M; Marco F; Salas A; Campo E; Siebert R; García-Orad A
Genes Chromosomes Cancer; 2011 Nov; 50(11):887-95. PubMed ID: 21910157
[TBL] [Abstract][Full Text] [Related]
23. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
Broeks A; Urbanus JH; de Knijff P; Devilee P; Nicke M; Klöpper K; Dörk T; Floore AN; van't Veer LJ
Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
[TBL] [Abstract][Full Text] [Related]
24. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association.
Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Chen C
Gynecol Oncol; 2006 Dec; 103(3):891-6. PubMed ID: 16806437
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
26. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
[TBL] [Abstract][Full Text] [Related]
28. Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy.
Yang M; Zhang L; Bi N; Ji W; Tan W; Zhao L; Yu D; Wu C; Wang L; Lin D
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1402-7. PubMed ID: 20729006
[TBL] [Abstract][Full Text] [Related]
29. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
31. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
Tapia T; Sanchez A; Vallejos M; Alvarez C; Moraga M; Smalley S; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2008 Jan; 107(2):281-8. PubMed ID: 17351744
[TBL] [Abstract][Full Text] [Related]
32. ATM missense variant P1054R predisposes to prostate cancer.
Meyer A; Wilhelm B; Dörk T; Bremer M; Baumann R; Karstens JH; Machtens S
Radiother Oncol; 2007 Jun; 83(3):283-8. PubMed ID: 17502119
[TBL] [Abstract][Full Text] [Related]
33. Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.
Tamimi RM; Hankinson SE; Spiegelman D; Kraft P; Colditz GA; Hunter DJ
Breast Cancer Res; 2004; 6(4):R416-22. PubMed ID: 15217510
[TBL] [Abstract][Full Text] [Related]
34. Discovering moderate-risk breast cancer susceptibility genes.
Hollestelle A; Wasielewski M; Martens JW; Schutte M
Curr Opin Genet Dev; 2010 Jun; 20(3):268-76. PubMed ID: 20346647
[TBL] [Abstract][Full Text] [Related]
35. Epistatic relationship between the cancer susceptibility genes CHEK2 and p27.
Cybulski C; Gliniewicz B; Sikorski A; Kładny J; Huzarski T; Gronwald J; Byrski T; Debniak T; Gorski B; Jakubowska A; Wokolorczyk D; Narod SA; Lubiñski J
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):572-6. PubMed ID: 17372254
[TBL] [Abstract][Full Text] [Related]
36. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
Baynes C; Healey CS; Pooley KA; Scollen S; Luben RN; Thompson DJ; Pharoah PD; Easton DF; Ponder BA; Dunning AM;
Breast Cancer Res; 2007; 9(2):R27. PubMed ID: 17428325
[TBL] [Abstract][Full Text] [Related]
37. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.
O'Mara TA; Ferguson K; Fahey P; Marquart L; Yang HP; Lissowska J; Chanock S; Garcia-Closas M; Thompson DJ; Healey CS; Dunning AM; Easton DF; ; Webb PM; Spurdle AB
Twin Res Hum Genet; 2011 Aug; 14(4):328-32. PubMed ID: 21787115
[TBL] [Abstract][Full Text] [Related]
38. Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk.
Einarsdóttir K; Humphreys K; Bonnard C; Palmgren J; Iles MM; Sjölander A; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
PLoS Med; 2006 Jun; 3(6):e168. PubMed ID: 16671833
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
Broeks A; Braaf LM; Huseinovic A; Schmidt MK; Russell NS; van Leeuwen FE; Hogervorst FB; Van 't Veer LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):243-8. PubMed ID: 17393301
[TBL] [Abstract][Full Text] [Related]
40. CHEK2 I157T and endometrial cancer.
Konstantinova DV; Kadiyska TK; Kaneva RP; Tosheva EG; Guseva VT; Dimitrov BH; Dimitrov RG; Doganov NI; Ivanov SI; Kremensky IM; Mitev VI
DNA Cell Biol; 2009 Jan; 28(1):9-12. PubMed ID: 18834326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
